Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Alzheimer Association

Global Dementia Trials Testing 158 Therapies May Need 350,000 Volunteers Because Strict Screening Turns Many Away

Dementia trials testing 158 therapies may need 350,000 volunteers to fill about 55,000 spots. Where U.S. families can search for trials and what to ask.

Medical Daily · Sep 22

Congress Funded a $41.5 Million CDC Dementia Program That No Longer Has Any Staff Left to Run It

Congress appropriated $41.5 million for CDC Alzheimer's programs, but the agency staff who ran them were cut, leaving grantees without federal support.

Medical Daily · Aug 18

A $100 Million Trial Launched Today to Test Whether GLP-1 Drugs Plus Lifestyle Changes Can Prevent Dementia

Alzheimer's Association launched the $100M PROTECT-Cog Study July 13, 2026 in London to test GLP-1 drugs plus lifestyle changes as dementia prevention. First global trial of its kind.

Medical Daily · Jul 14

From analysis to the latest developments in health,
read the most diverse news in one place.

New Alzheimer’s Blood Test Leads To Early Detection And Treatment

A new Alzheimer’s blood test recently approved by the U. S. Food and Drug Administration (FDA) can now detect the disease in people with early...

Saving Advice · Jun 9, 2025

Alzheimer’s rates highest in Texas border counties, new study shows

Texas’ border counties have higher rates of Alzheimer’s disease among older adults than other areas in the state, according to a new study estimating county-level prevalence of the neurodegenerative disease.

Tribune News Service · Jul 18, 2023

Alzheimer’s report hints at a future health crisis bigger than COVID-19

The costs of Alzheimer’s disease – human and financial – are rising sharply in California and nationally, and census projections for America’s rapidly aging population suggest the scope of the disease soon might rival what America saw during the height of the COVID-19 pandemic.

The Orange County Register · Mar 21, 2023

Dementia care programs help, if caregivers can find them

There’s no cure, yet, for Alzheimer’s disease. But dozens of programs developed in the past 20 years can improve the lives of both people living with dementia and their caregivers.

Tribune News Service · Mar 3, 2023

Read news from The Economist, FT, and more,
with one subscription

Why a new Alzheimer's drug is having a slow US debut

The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away

The Independent UK · Feb 4, 2023

Commentary: Too soon to celebrate new Alzheimer’s drug

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

Tribune News Service · Jan 25, 2023

Why do some people get Alzheimer’s and others don’t? How a new tool checks your risk

Why do some people develop Alzheimer’s disease and others don’t? What makes one person’s brain healthier than another’s? And what can be done to improve, or at least slow, a brain’s deterioration?

Miami Herald · Dec 29, 2022

They live with Alzheimer's. Here's how they want to be treated during the holidays—in their own words

Living with Alzheimer's can feel isolating, especially during the holidays. Having support matters because "you can't fight this battle alone."

Fortune · Dec 21, 2022

Bud Harrelson’s family, teammates working to make sure nobody forgets about beloved former Met

NEW YORK — It was something so normal: Just two former teammates playing catch.

Tribune News Service · Dec 11, 2022

New Alzheimer's drug faces uncertain regulatory path

The FDA will soon decide whether to approve Eisai's experimental drug lecanemab.

Axios · Nov 30, 2022

Florida doctors use saliva test to reveal someone’s future risk for Alzheimer’s

Florida doctors are using a new test to determine someone’s future risk for Alzheimer’s disease from a few drops of spit.

Tribune News Service · Nov 11, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service · Oct 14, 2022

For Alzheimer’s patients, a controversial drug brings hope

TAMPA, Fla. -- At 53, Michele Hall was at the height of her legal career. She’d just sent her three kids to college. She had decades ahead with her husband Doug — after nearly 30 years of marriage, the couple looked forward to celebrating 30 more.

The Guardian - UK · Sep 14, 2022

Daily multi-vitamins may improve brain function in older people – US study

Trial finds supplements could slow decline by 60% but Alzheimer’s and dementia experts caution larger studies needed

The Independent UK · Sep 14, 2022

Taking multivitamins may protect against cognitive decline in over-65s – study

But researchers say more studies are needed to confirm the findings before health recommendations can be made.

WEKU · Sep 12, 2022

With early Alzheimer's in the family, these sisters decided to test for the gene

For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse · Aug 25, 2022

Alzheimer's disease has no cure — but unproven treatments claim otherwise

Frustrated by a lack of mainstream medical treatments, Alzheimer’s disease and dementia patients look to unproven alternatives that promise to end and reverse these incurable diseases.

Chicago Sun-Times · Aug 3, 2022

Even simple exercise might help older people’s brains, new study suggests

The new study presented at the Alzheimer’s Association’s annual conference marks the longest test of whether exercise makes any difference once memory starts to slide.

Benzinga · Jul 27, 2022

LGVN: Alzheimer's Study Gains Traction as CEO Search Continues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga · Apr 1, 2022

LGVN: LGVN Publishes Positive Alzheimer's Results

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

the Food and Drug Administration

the Alzheimer Association

52 stories

Alzheimer Association

22 stories

the National Institute on Aging

22 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.